Within a large healthcare system, the incidence of positive COVID-19 results and mortality are lower in patients on chronic hydroxychloroquine therapy

被引：0

作者：

Soma Sen

Ann Werner

Aditya Shekhar

机构：

[1] Park Nicollet Heart and Vascular Center,

[2] HealthPartners Institute,undefined

[3] The University of Chicago,undefined

[4] The University of Minnesota,undefined

来源：

Drugs & Therapy Perspectives | 2020年 / 36卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：298 / 299

页数：1

共 9 条

[1]

Yao X(2020)In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin Infect Dis 55 105932-undefined

[2]

Ye F(2020)Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Int J Antimicrob Agents undefined undefined-undefined

[3]

Zhang M(2020)Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 [editorial] Int J Antimicrob Agents undefined undefined-undefined

[4]

Gautret P(undefined)undefined undefined undefined undefined-undefined

[5]

Lagier JC(undefined)undefined undefined undefined undefined-undefined

[6]

Parola P(undefined)undefined undefined undefined undefined-undefined

[7]

Colson P(undefined)undefined undefined undefined undefined-undefined

[8]

Rolain JM(undefined)undefined undefined undefined undefined-undefined

[9]

Lagier JC(undefined)undefined undefined undefined undefined-undefined

← 1 →